Let me continue, if I could.
The point I want to make is that there are differences between Brazil and Canada. For example, if you take AstraZeneca, there are clinical trials occurring in Brazil. Clinical trials are not occurring in Canada. Another point to mention is biomanufacturing capability. There is that capacity in Brazil. There isn't in Canada.
There are differences between these jurisdictions that in turn lead to different contracts between them.